Learn More
Roche Diagnostics Cobas™ Liat CT/NG/MG RT-PCR Assay Kit
The Cobas™ liat CT/NG/MG test is an automated, qualitative in vitro nucleic acid diagnostic using real-time PCR for the detection of CT, NG, and MG in male urine and vaginal swabs.
Supplier: Roche Diagnostics 09449604190
Description
The cobas™ liat CT/NG/MG nucleic acid test is an automated, qualitative in vitro nucleic acid diagnostic test that utilizes real- time polymerase chain reaction (PCR) for the direct detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Mycoplasma genitalium (MG) nucleic acid in male urine and vaginal swabs, all in cobas™ PCR Media (Roche Molecular Systems, Inc.). This test is intended as an aid in the diagnosis of urogenital infections in both symptomatic and asymptomatic patients.

Specifications
20 tests per kit; store at 2° to 8 °C | |
Chlamydia trachomatis, N. gonorrhoeae, Mycoplasma IgG | |
PCR test | |
20 tests per kit; pipettes | |
Chlamydia: male urine (99.9%); vaginal swab (99.8%). Gonorrhea: male urine (99.9%); vaginal swab (99.8%). Mycoplasma Genitalium: male urine (99.2%); vaginal swab (97.8%) | |
10.7 x 6.5 x 5.7 in. | |
Ready-to-Use (RTU) |
Waived | |
Chlamydia: male urine (97.3%); vaginal swab (98.2%). Gonorrhea: male urine (100.0%); vaginal swab (97.7%). Mycoplasma Genitalium: male urine (97.1%); vaginal swab (95.2%) | |
The cobas™ liat CT/NG/MG test is an automated, qualitative in vitro nucleic acid diagnostic using real-time PCR for the detection of CT, NG, and MG in male urine and vaginal swabs. For use with the cobas liat system. | |
20 tests per kit | |
20 minutes | |
2.4 lb. | |
2°C to 8°C |
Safety and Handling
ShelfLife : 18-months
Your input is important to us. Please complete this form to provide feedback related to the content on this product.